This announcement is a separate document:
Achilles Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Forbion Capital Fund IV Coöperatief U.A.(5.89%),Forbion IV Management B.V.(5.89%)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.